82 FR 18305 - Office of the Secretary; Notice of Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 73 (April 18, 2017)

Page Range		18305-18306
FR Document		2017-07739

Federal Register, Volume 82 Issue 73 (Tuesday, April 18, 2017)

[Federal Register Volume 82, Number 73 (Tuesday, April 18, 2017)]
[Notices]
[Pages 18305-18306]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-07739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meetings

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the Task 
Force on Research Specific to Pregnant Women and Lactating Women.
    The meetings will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Task Force on Research Specific to Pregnant 
Women and Lactating Women.
    Date: August 21-22, 2017.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: The Task Force is charged with providing advice and 
guidance to the Secretary of HHS, regarding Federal activities 
related to identifying and addressing gaps in knowledge and research 
regarding safe and effective therapies for pregnant women and 
lactating women, including the development of such therapies and the 
collaboration on and coordination of such activities.
    Place: National Institutes of Health, Building 31, C-Wing, 
Conference Rm. 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice 
Kennedy Shriver National Institute of Child Health and Human 
Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD 
20892, (301) 496-0536, kaeserl@mail.nih.gov.

    Name of Committee: Task Force on Research Specific to Pregnant 
Women and Lactating Women.
    Date: November 6-7, 2017.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: The Task Force is charged with providing advice and 
guidance to the Secretary of HHS, regarding Federal activities 
related to identifying and addressing gaps in knowledge and research 
regarding safe and effective therapies for pregnant women and 
lactating women, including the development of such therapies and the 
collaboration on and coordination of such activities.
    Place: National Institutes of Health, Conference Rm. C-D, 6001 
Executive Blvd., Rockville, MD 20852.
    Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice 
Kennedy Shriver National Institute of Child Health and Human

[[Page 18306]]

Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD 
20892, (301) 496-0536, kaeserl@mail.nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: April 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07739 Filed 4-17-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 73 / Tuesday, April 18, 2017 / Notices 18305

DEPARTMENT OF HEALTH AND will be inspected before being allowed on Dated: April 12, 2017.
HUMAN SERVICES campus. Visitors will be asked to show one David Clary,
form of identification (for example, a Program Analyst, Office of Federal Advisory
National Institutes of Health government-issued photo ID, driver’s license, Committee Policy.
or passport) and to state the purpose of their [FR Doc. 2017–07734 Filed 4–17–17; 8:45 am]
National Institute on Deafness and visit.
BILLING CODE 4140–01–P
Other Communication Disorders; Information is also available on the
Notice of Meeting Institute’s/Center’s home page: http://
www.nidcd.nih.gov/about/Pages/Advisory-
Pursuant to section 10(d) of the Groups-and-Review-Committees.aspx, where
DEPARTMENT OF HEALTH AND
Federal Advisory Committee Act, as an agenda and any additional information for HUMAN SERVICES
amended (5 U.S.C. App.), notice is the meeting will be posted when available.
hereby given of a meeting of the National Institutes of Health
(Catalogue of Federal Domestic Assistance
National Deafness and Other Program Nos. 93.173, Biological Research Office of the Secretary; Notice of
Communication Disorders Advisory Related to Deafness and Communicative Meetings
Council. Disorders, National Institutes of Health, HHS)
The meeting will be open to the Pursuant to section 10(a) of the
Dated: April 12, 2017.
public as indicated below, with Federal Advisory Committee Act, as
attendance limited to space available. Sylvia L. Neal, amended (5 U.S.C. App.), notice is
Individuals who plan to attend and Program Analyst, Office of Federal Advisory hereby given of meetings of the Task
need special assistance, such as sign Committee Policy. Force on Research Specific to Pregnant
language interpretation or other [FR Doc. 2017–07735 Filed 4–17–17; 8:45 am] Women and Lactating Women.
reasonable accommodations, should BILLING CODE 4140–01–P The meetings will be open to the
notify the Contact Person listed below public, with attendance limited to space
in advance of the meeting. available. Individuals who plan to
The meeting will be closed to the DEPARTMENT OF HEALTH AND attend and need special assistance, such
public in accordance with the HUMAN SERVICES as sign language interpretation or other
provisions set forth in sections reasonable accommodations, should
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institutes of Health notify the Contact Person listed below
as amended. The grant applications in advance of the meeting.
and/or contract proposals and the National Institute of Biomedical
Imaging and Bioengineering; Notice of Name of Committee: Task Force on
discussions could disclose confidential Research Specific to Pregnant Women and
trade secrets or commercial property Closed Meeting Lactating Women.
such as patentable material, and Date: August 21–22, 2017.
personal information concerning Pursuant to section 10(d) of the Time: 8:00 a.m. to 5:30 p.m.
individuals associated with the grant Federal Advisory Committee Act, as Agenda: The Task Force is charged with
applications and/or contract proposals, amended (5 U.S.C. App.), notice is providing advice and guidance to the
hereby given of the following meeting. Secretary of HHS, regarding Federal activities
the disclosure of which would related to identifying and addressing gaps in
constitute a clearly unwarranted The meeting will be closed to the knowledge and research regarding safe and
invasion of personal privacy. public in accordance with the effective therapies for pregnant women and
Name of Committee: National Deafness and provisions set forth in sections lactating women, including the development
Other Communication Disorders Advisory 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., of such therapies and the collaboration on
Council. as amended. The grant applications and and coordination of such activities.
Date: May 19, 2017. the discussions could disclose Place: National Institutes of Health,
Closed: 8:30 a.m. to 9:40 a.m. confidential trade secrets or commercial Building 31, C-Wing, Conference Rm. 6, 31
Agenda: To review and evaluate grant property such as patentable material, Center Drive, Bethesda, MD 20892.
applications. Contact Person: Ms. Lisa Kaeser, Executive
and personal information concerning
Place: National Institutes of Health, Secretary, Eunice Kennedy Shriver National
individuals associated with the grant Institute of Child Health and Human
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892. applications, the disclosure of which Development, 31 Center Drive, Room 2A03,
Open: 9:40 a.m. to 2:00 p.m. would constitute a clearly unwarranted MSC 2425, Bethesda, MD 20892, (301) 496–
Agenda: Staff reports on divisional, invasion of personal privacy. 0536, kaeserl@mail.nih.gov.
programmatic, and special activities. Name of Committee: National Institute of Name of Committee: Task Force on
Place: National Institutes of Health, Biomedical Imaging and Bioengineering Research Specific to Pregnant Women and
Building 31, Conference Room 6, 31 Center Special Emphasis Panel; MSM Program Lactating Women.
Drive, Bethesda, MD 20892. Date: November 6–7, 2017.
Review (2017/10).
Contact Person: Craig A. Jordan, Ph.D., Time: 8:00 a.m. to 5:30 p.m.
Date: June 6, 2017.
Director, Division of Extramural Activities, Agenda: The Task Force is charged with
NIDCD, NIH, Room 8345, MSC 9670, 6001 Time: 10:00 a.m. to 5:00 p.m.
providing advice and guidance to the
Executive Blvd., Bethesda, MD 20892–9670, Agenda: To review and evaluate grant
Secretary of HHS, regarding Federal activities
301–496–8693, jordanc@nidcd.nih.gov. applications.
related to identifying and addressing gaps in
Place: National Institutes of Health, Two knowledge and research regarding safe and
Any interested person may file written
comments with the committee by forwarding Democracy Plaza, 6707 Democracy effective therapies for pregnant women and
the statement to the Contact Person listed on Boulevard, Suite 920, Bethesda, MD 20892 lactating women, including the development
sradovich on DSK3GMQ082PROD with NOTICES

this notice. The statement should include the (Virtual Meeting). of such therapies and the collaboration on
name, address, telephone number and when Contact Person: Manana Sukhareva, Ph.D., and coordination of such activities.
applicable, the business or professional Scientific Review Officer, National Institute Place: National Institutes of Health,
affiliation of the interested person. of Biomedical Imaging and Bioengineering, Conference Rm. C–D, 6001 Executive Blvd.,
In the interest of security, NIH has National Institutes of Health, 6707 Rockville, MD 20852.
instituted stringent procedures for entrance Democracy Boulevard, Suite 959, Bethesda, Contact Person: Ms. Lisa Kaeser, Executive
onto the NIH campus. All visitor vehicles, MD 20892, (301) 451–3397, sukharem@ Secretary, Eunice Kennedy Shriver National
including taxicabs, hotel, and airport shuttles mail.nih.gov. Institute of Child Health and Human

VerDate Sep<11>2014 16:55 Apr 17, 2017 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\18APN1.SGM 18APN1

18306 Federal Register / Vol. 82, No. 73 / Tuesday, April 18, 2017 / Notices

Development, 31 Center Drive, Room 2A03, Vascular Diseases Research; 93.838, Lung DEA, NIDDK, National Institutes of Health,
MSC 2425, Bethesda, MD 20892, (301) 496– Diseases Research; 93.839, Blood Diseases Room 7349, 6707 Democracy Boulevard,
0536, kaeserl@mail.nih.gov. and Resources Research, National Institutes Bethesda, MD 20892–5452, (301) 594–8894,
Any interested person may file written of Health, HHS) begumn@niddk.nih.gov.
comments with the committee by forwarding Dated: April 12, 2017. Name of Committee: National Institute of
the statement to the Contact Person listed on Michelle Trout, Diabetes and Digestive and Kidney Diseases
this notice. The statement should include the Special Emphasis Panel; NIDDK Diabetes
name, address, telephone number and when Program Analyst, Office of Federal Advisory Research Centers (P30).
applicable, the business or professional Committee Policy. Date: May 24–25, 2017.
affiliation of the interested person. [FR Doc. 2017–07740 Filed 4–17–17; 8:45 am] Time: 8:00 a.m. to 6:00 p.m.
In the interest of security, NIH has BILLING CODE 4140–01–P Agenda: To review and evaluate grant
instituted stringent procedures for entrance applications.
onto the NIH campus. All visitor vehicles, Place: DoubleTree by Hilton, Ballroom C,
including taxicabs, hotel, and airport shuttles DEPARTMENT OF HEALTH AND 8120 Wisconsin Avenue, Bethesda, MD
will be inspected before being allowed on 20814.
HUMAN SERVICES
campus. Visitors will be asked to show one Contact Person: Najma Begum, Ph.D.,
form of identification (for example, a Scientific Review Officer, Review Branch,
National Institutes of Health
government-issued photo ID, driver’s license, DEA, NIDDK, National Institutes of Health,
or passport) and to state the purpose of their Room 7349, 6707 Democracy Boulevard,
National Institute of Diabetes and Bethesda, MD 20892–5452, (301) 594–8894,
visit.
Digestive and Kidney Diseases; Notice begumm@niddk.nih.gov.
Dated: April 12, 2017. of Closed Meetings (Catalogue of Federal Domestic Assistance
Michelle Trout,
Pursuant to section 10(d) of the Program Nos. 93.847, Diabetes,
Program Analyst, Office of Federal Advisory Endocrinology and Metabolic Research;
Committee Policy. Federal Advisory Committee Act, as
93.848, Digestive Diseases and Nutrition
amended (5 U.S.C. App.), notice is
[FR Doc. 2017–07739 Filed 4–17–17; 8:45 am] Research; 93.849, Kidney Diseases, Urology
hereby given of the following meetings. and Hematology Research, National Institutes
BILLING CODE 4140–01–P
The meetings will be closed to the of Health, HHS)
public in accordance with the
provisions set forth in sections Dated: April 12, 2017.
DEPARTMENT OF HEALTH AND David Clary,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
HUMAN SERVICES Program Analyst, Office of Federal Advisory
as amended. The grant applications and
the discussions could disclose Committee Policy.
National Institutes of Health
confidential trade secrets or commercial [FR Doc. 2017–07736 Filed 4–17–17; 8:45 am]
National Heart, Lung, and Blood property such as patentable material, BILLING CODE 4140–01–P
Institute; Notice of Closed Meeting and personal information concerning
individuals associated with the grant
Pursuant to section 10(d) of the applications, the disclosure of which DEPARTMENT OF HEALTH AND
Federal Advisory Committee Act, as would constitute a clearly unwarranted HUMAN SERVICES
amended (5 U.S.C. App.), notice is invasion of personal privacy.
hereby given of the following meeting. National Institutes of Health
The meeting will be closed to the Name of Committee: National Institute of
public in accordance with the Diabetes and Digestive and Kidney Diseases Request for Information on Input on
provisions set forth in sections Special Emphasis Panel; NIDDK Central Opportunities of Engagement of
Biorepositories Non-renewable Sample External Stakeholders With the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Access (X01) PAR–14–301.
as amended. The grant applications and Date: May 11, 2017.
‘‘Illuminating the Druggable Genome’’
the discussions could disclose Time: 1:00 p.m. to 2:30 p.m. (IDG) Program
confidential trade secrets or commercial Agenda: To review and evaluate grant SUMMARY: NIH seeks input from the
property such as patentable material, applications. biomedical research community,
and personal information concerning Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
biotechnology and pharmaceutical
individuals associated with the grant companies and other members of the
applications, the disclosure of which Boulevard, Bethesda, MD 20892 (Telephone
Conference Call). public on interest and opportunities of
would constitute a clearly unwarranted engagement with the Illuminating the
Contact Person: Najma Begum, Ph.D.,
invasion of personal privacy. Scientific Review Officer, Review Branch, Druggable Genome (IDG) Program. The
Name of Committee: National Heart, Lung, DEA, NIDDK, National Institutes of Health, purpose of this Request for Information
and Blood Institute Special Emphasis Panel; Room 7349, 6707 Democracy Boulevard, (RFI) is to identify and obtain comments
Genetic Basis and/or Omics Phenotypes of Bethesda, MD 20892–5452, (301) 594–8894, on strategies for sharing potential data,
Heart, Lung and Blood Disorders. begumn@niddk.nih.gov. tools, and other resources of common
Date: May 12, 2017. Name of Committee: National Institute of
Time: 8:00 a.m. to 5:00 p.m.
interest generated by the IDG Program
Diabetes and Digestive and Kidney Diseases and by external stakeholders to
Agenda: To review and evaluate grant Special Emphasis Panel; PAR–16–034:
applications. NIDDK Ancillary Studies to Major Ongoing
maximize the impact of the IDG
Place: Residence Inn Bethesda, 7335 Clinical Studies (R01). Program.
Wisconsin Avenue, Bethesda, MD 20814. Date: May 15, 2017. DATES: The IDG Program Request for
Contact Person: Chang Sook Kim, Ph.D., Time: 2:00 p.m. to 4:00 p.m. Information is open for public comment
sradovich on DSK3GMQ082PROD with NOTICES

Scientific Review Officer, Office of Scientific Agenda: To review and evaluate grant
Review/DERA, National Heart, Lung, and
for a period of 30 days. Comments must
applications. be received by May 18, 2017 to ensure
Blood Institute, 6701 Rockledge Drive, Room Place: National Institutes of Health, Two
7188, Bethesda, MD 20892–7924, 301–435– Democracy Plaza, 6707 Democracy
consideration. After the public comment
0287, carolko@mail.nih.gov. Boulevard, Bethesda, MD 20892 (Telephone period has closed, the comments
(Catalogue of Federal Domestic Assistance Conference Call). received by the IDG Program will be
Program Nos. 93.233, National Center for Contact Person: Najma Begum, Ph.D., considered in a timely manner by the
Sleep Disorders Research; 93.837, Heart and Scientific Review Officer, Review Branch, National Center for Advancing

VerDate Sep<11>2014 16:55 Apr 17, 2017 Jkt 241001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\18APN1.SGM 18APN1

Document Created: 2017-04-18 00:00:31
Document Modified: 2017-04-18 00:00:31

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		August 21-22, 2017.
FR Citation		82 FR 18305

82 FR 18305 - Office of the Secretary; Notice of Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 73 (April 18, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health